Your browser doesn't support javascript.
loading
Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial.
Tong, T M L; van der Kooij, M K; Speetjens, F M; van Erkel, A R; van der Meer, R W; Lutjeboer, J; van Persijn van Meerten, E L; Martini, C H; Zoethout, R W M; Tijl, F G J; Blank, C U; Burgmans, M C; Kapiteijn, E.
Affiliation
  • Tong TML; Department of Medical Oncology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands. T.M.L.Tong@lumc.nl.
  • van der Kooij MK; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands. T.M.L.Tong@lumc.nl.
  • Speetjens FM; Department of Medical Oncology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • van Erkel AR; Department of Medical Oncology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • van der Meer RW; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • Lutjeboer J; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • van Persijn van Meerten EL; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • Martini CH; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • Zoethout RWM; Department of Anesthesiology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • Tijl FGJ; Department of Anesthesiology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • Blank CU; Department of Extra Corporal Circulation, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • Burgmans MC; Department of Medical Oncology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • Kapiteijn E; Department of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL), PO Box 90203, 1006, BE, Amsterdam, The Netherlands.
Trials ; 23(1): 137, 2022 Feb 13.
Article in En | MEDLINE | ID: mdl-35152908
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uveal Neoplasms / Chemotherapy, Cancer, Regional Perfusion / Melanoma Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uveal Neoplasms / Chemotherapy, Cancer, Regional Perfusion / Melanoma Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido